Can creatine cause hair loss? It is one of the most searched questions among UK gym-goers and athletes considering this popular sports supplement. Creatine monohydrate is widely used to support high-intensity exercise performance and is sold legally across the UK in health food shops, gyms, and online. Despite its strong safety record, a single 2009 study suggesting a rise in dihydrotestosterone (DHT) — a hormone linked to androgenetic alopecia — sparked ongoing debate. This article examines the evidence critically, explains the proposed biological mechanism, identifies who may be at greater risk, and outlines practical steps to take if you notice hair changes while supplementing.
Summary: Can creatine cause hair loss? Current evidence does not conclusively prove that creatine causes hair loss, though one small 2009 study found it may raise DHT levels — a hormone associated with androgenetic alopecia — in genetically susceptible individuals.
- Creatine monohydrate is a legal, widely researched sports supplement endorsed by EFSA for improving short-term, high-intensity exercise performance at 3 g per day.
- A single 2009 study (n=20) found creatine raised the DHT-to-testosterone ratio; DHT is the primary androgen implicated in male and female pattern hair loss.
- Hair loss itself was not measured in the 2009 study, and its findings have not been reliably replicated; no MHRA safety alerts or NICE guidance link creatine to alopecia.
- The proposed mechanism — creatine enhancing 5-alpha reductase conversion of testosterone to DHT — remains biologically plausible but unproven in human clinical trials.
- Those with a personal or family history of androgenetic alopecia may theoretically carry greater susceptibility, though no clinical studies confirm higher risk in any specific group.
- Creatine should be avoided in renal disease, pregnancy, and under-18s without professional supervision; suspected adverse reactions should be reported via the MHRA Yellow Card scheme.
Table of Contents
- What Is Creatine and How Is It Used in the UK?
- The Link Between Creatine and Hair Loss: What the Evidence Shows
- How DHT May Play a Role in Creatine-Related Hair Thinning
- Who May Be More at Risk of Hair Loss When Taking Creatine
- What to Do If You Notice Hair Loss While Using Creatine
- NHS and MHRA Guidance on Creatine Supplement Safety
- Frequently Asked Questions
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
What Is Creatine and How Is It Used in the UK?
Creatine monohydrate is a legal, over-the-counter sports supplement widely used in the UK to support ATP regeneration during high-intensity exercise. EFSA confirms 3 g daily improves short-burst performance; it is not a steroid and does not typically raise testosterone.
Creatine is a naturally occurring compound synthesised in the body from amino acids — primarily in the liver, kidneys, and pancreas. It is also obtained through dietary sources such as red meat and fish. Within the body, creatine plays a central role in energy metabolism, particularly during short bursts of high-intensity physical activity, by helping to regenerate adenosine triphosphate (ATP), the primary energy currency of cells.
As a sports supplement, creatine monohydrate is one of the most widely used and extensively researched ergogenic aids available in the UK. It is legally sold over the counter in health food shops, gyms, and online retailers, and is popular among athletes, bodybuilders, and recreational gym-goers. The European Food Safety Authority (EFSA) has concluded that 3 g of creatine per day increases physical performance in successive bursts of short-term, high-intensity exercise — a finding that underpins its widespread use. Common supplementation protocols involve a loading phase of around 20 g per day for five to seven days, followed by a maintenance dose of 3–5 g daily, though many users skip the loading phase entirely.
The NHS acknowledges creatine as one of the few sports supplements with a credible evidence base for improving high-intensity exercise performance and supporting training adaptations; evidence for broader recovery benefits is more mixed. It is important to note that creatine is not a steroid and does not generally increase testosterone levels in healthy users. However, its potential indirect effects on certain hormonal pathways have prompted questions — most notably, can creatine cause hair loss? This concern, while not yet conclusively proven, has gained traction in fitness communities and warrants a careful, evidence-based examination.
Not sure if this is normal? Chat with one of our pharmacists →
| Aspect | Detail | Evidence Level | Practical Advice |
|---|---|---|---|
| Proposed mechanism | Creatine may increase DHT-to-testosterone ratio via enhanced 5-alpha reductase activity | Single small study (n=20); not replicated | Treat as hypothetical; no confirmed causal link |
| Key study | Van der Merwe et al., 2009 — elevated DHT levels in male rugby players taking creatine vs placebo | Low (small RCT; hair loss not measured) | Do not extrapolate beyond DHT levels; no hair outcome data |
| Regulatory position | No MHRA safety alerts or NICE guidance link creatine to alopecia | Regulatory consensus | Report suspected reactions via MHRA Yellow Card scheme |
| Who may be at higher risk | Men with family history of androgenetic alopecia; women with PCOS or androgen sensitivity | Theoretical only; no clinical studies confirm higher risk | Consider personal and family hair-loss history before supplementing |
| If hair loss is noticed | Pause creatine for 8–12 weeks; review other causes (iron, ferritin, thyroid, vitamin D, stress) | Expert consensus / clinical practice | Consult GP if rapid, patchy, or accompanied by systemic symptoms |
| Available treatments for androgenetic alopecia | Finasteride (prescription only, 5-alpha reductase inhibitor); topical minoxidil (OTC) | NICE / MHRA licensed indications | Do not self-prescribe; seek GP or pharmacist guidance before starting |
| General safety cautions | Avoid in renal disease; not recommended under-18s; insufficient data in pregnancy/breastfeeding | FSA / NHS guidance | Buy from Informed-Sport certified retailers; seek medical advice if on medication |
The Link Between Creatine and Hair Loss: What the Evidence Shows
No established clinical link between creatine and hair loss exists; the concern stems from a single 2009 study of 20 men that measured raised DHT levels — not hair loss itself — and has not been reliably replicated.
The question of whether creatine can cause hair loss largely stems from a single study published in 2009 in the Clinical Journal of Sport Medicine (van der Merwe et al., 2009). In this randomised, double-blind, placebo-controlled trial conducted on college-aged male rugby players in South Africa, participants who took creatine supplements showed a statistically significant increase in serum levels of dihydrotestosterone (DHT) compared to those taking a placebo. DHT is a potent androgen known to contribute to androgenetic alopecia — the most common form of hair loss in both men and women.
However, it is crucial to interpret this study with appropriate caution:
-
The study involved only 20 participants, making it too small to draw broad conclusions.
-
Hair loss itself was not measured — only DHT levels were assessed.
-
The findings have not been replicated in subsequent studies; importantly, most creatine trials have not assessed DHT levels or hair outcomes at all, so the absence of a consistent signal may partly reflect a lack of measurement rather than confirmed safety.
-
There are no MHRA safety alerts or NICE guidance linking creatine supplementation to hair loss or alopecia.
At present, there is no established clinical link between creatine use and hair loss confirmed by robust human trials. The broader body of research on creatine — spanning hundreds of studies — does not consistently identify alopecia as a side effect. While the DHT hypothesis is biologically plausible, it remains speculative without further corroborating evidence. Patients and consumers should therefore approach claims about creatine and hair loss with measured scepticism, neither dismissing the concern entirely nor treating it as established fact.
Experiencing these side effects? Our pharmacists can help you navigate them →
How DHT May Play a Role in Creatine-Related Hair Thinning
Creatine may increase the DHT-to-testosterone ratio by enhancing 5-alpha reductase activity, potentially accelerating follicle miniaturisation in genetically susceptible individuals, though this mechanism remains hypothetical and unproven in human studies.
To understand the proposed mechanism, it is helpful to consider how DHT affects hair follicles. Dihydrotestosterone is formed when the enzyme 5-alpha reductase converts testosterone into its more potent derivative. In individuals with a genetic predisposition to androgenetic alopecia, DHT binds to androgen receptors in hair follicles — particularly those on the scalp — causing them to miniaturise over time. This progressive shrinkage shortens the hair growth cycle and eventually leads to finer, shorter hairs and, ultimately, follicle dormancy. This mechanism is well described in UK clinical resources, including NICE Clinical Knowledge Summaries on male pattern hair loss and guidance from the British Association of Dermatologists.
The 2009 study referenced above found that creatine supplementation was associated with an increase in the DHT-to-testosterone ratio, suggesting that creatine may enhance the conversion of testosterone to DHT rather than raising testosterone levels directly. If this effect is real and reproducible, it could theoretically accelerate hair follicle miniaturisation in genetically susceptible individuals — even without raising total testosterone. However, the clinical significance of any such change for hair outcomes remains uncertain and has not been demonstrated in human studies.
It is worth emphasising that this mechanism is indirect and hypothetical based on current evidence. Creatine does not act as a hormonal agent in the conventional pharmacological sense; it does not bind to androgen receptors or directly stimulate steroidogenesis. Any influence on DHT levels, if genuine, would likely be modest. Treatments that directly target the DHT pathway — such as finasteride, a 5-alpha reductase inhibitor licensed in the UK for male pattern baldness (available on prescription; see the electronic Medicines Compendium SmPC for finasteride 1 mg) — work through a well-established mechanism that creatine does not replicate. This distinction is important when contextualising the potential risk.
Who May Be More at Risk of Hair Loss When Taking Creatine
Individuals with a family history of androgenetic alopecia or androgen-sensitive conditions such as PCOS are theoretically at greater risk, though no clinical studies confirm creatine causes greater hair loss in any specific population.
If there is any genuine association between creatine and hair thinning, it is most likely to be relevant in individuals who already carry a genetic predisposition to androgenetic alopecia. This condition — commonly known as male or female pattern baldness — is polygenic and influenced by the sensitivity of hair follicles to androgens, particularly DHT. Those with a family history of early-onset hair loss on either the maternal or paternal side may have follicles that are more reactive to even modest changes in DHT levels.
Based on the theoretical mechanism, groups who may wish to exercise additional caution include:
-
Men with a family history of male pattern baldness, particularly those who have already noticed early signs such as a receding hairline or thinning at the crown.
-
Women with androgenetic alopecia or polycystic ovary syndrome (PCOS), conditions associated with elevated androgen sensitivity — though no studies have demonstrated a higher risk of hair loss with creatine specifically in these groups.
It is important to stress that these risk groups are theoretical, based on the plausible but unproven DHT hypothesis. No clinical studies have demonstrated that creatine causes greater hair loss in any particular population. The vast majority of creatine users do not report hair loss, and many individuals with genetic predispositions use creatine without any noticeable effect on their hair. Lifestyle factors — including stress, nutritional deficiencies, and underlying health conditions — are far more commonly implicated in hair loss than supplement use. A thorough personal and family history remains the most useful tool for assessing individual risk.
What to Do If You Notice Hair Loss While Using Creatine
If hair shedding begins after starting creatine, consider pausing use for 8–12 weeks, reviewing other causes such as nutritional deficiencies or thyroid dysfunction, and seeking GP review if red-flag features such as patchy loss, scalp changes, or systemic symptoms are present.
If you begin to notice increased hair shedding, thinning, or changes in hair density after starting creatine supplementation, it is sensible to take a measured and systematic approach rather than immediately attributing the change to the supplement.
Practical steps to consider:
-
Monitor the pattern and timeline of hair loss. Diffuse shedding that began shortly after starting creatine may warrant further investigation, whereas gradual thinning consistent with a family pattern is more likely to be androgenetic in origin.
-
Consider pausing creatine use for eight to twelve weeks to observe whether hair shedding stabilises or improves. This informal washout period can help clarify whether there is a temporal relationship.
-
Review other potential causes, including nutritional deficiencies (particularly iron, ferritin, vitamin D, and zinc), thyroid dysfunction, significant physical or emotional stress, and recent changes in diet or medication. Any investigations — such as ferritin, TSH, or vitamin D — should be guided by your clinical history and examination, and arranged through your GP.
-
Seek prompt GP review if you experience any of the following red-flag features: rapid or extensive hair loss; patchy loss (which may suggest alopecia areata); loss of eyebrows or eyelashes; scalp pain, redness, scaling, or scarring; systemic symptoms such as fatigue or weight change; or, in women, signs of hyperandrogenism such as hirsutism, acne, or menstrual irregularity. These features warrant clinical assessment and possible referral to a dermatologist. The NHS hair loss pages provide useful guidance on when to seek help.
Regarding treatments: finasteride is a prescription-only medicine — discuss with your GP if you are considering it, as it requires proper clinical assessment. Topical minoxidil is available over the counter in the UK for appropriate candidates; speak to a pharmacist or your GP before starting, to confirm it is suitable for you. Do not self-prescribe either treatment without professional guidance, as both carry their own side effect profiles.
NHS and MHRA Guidance on Creatine Supplement Safety
Creatine is regulated as a food supplement in the UK, with no MHRA safety alerts or NICE guidance linking it to hair loss; suspected adverse reactions should be reported via the Yellow Card scheme, and third-party tested products carrying Informed-Sport certification are recommended.
In the UK, food supplements — including creatine — are regulated under food law rather than medicines legislation. This means they do not require pre-market approval from the Medicines and Healthcare products Regulatory Agency (MHRA) before being sold, provided they do not make medicinal claims. The Food Standards Agency (FSA) oversees food supplement safety in Great Britain, and the EFSA has concluded that creatine at 3 g per day is effective for short-term, high-intensity exercise performance; the available evidence suggests that creatine at recommended intakes is acceptable for healthy adults, though long-term safety data — particularly in adolescents and those with pre-existing health conditions — remains limited.
The NHS acknowledges creatine as one of the few sports supplements with a credible evidence base for improving high-intensity exercise performance, while noting that supplements are not a substitute for a balanced diet.
Regarding hair loss specifically, there are no MHRA safety alerts or NICE guidance linking creatine supplementation to alopecia. Suspected adverse reactions to any supplement can and should be reported to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk), which helps build the national evidence base for supplement safety.
Important cautions to be aware of:
-
Renal disease: creatine should be avoided or used only under medical supervision in individuals with kidney problems.
-
Pregnancy and breastfeeding: seek medical advice before use, as safety data are insufficient.
-
Adolescents: creatine supplementation is not recommended for under-18s without professional supervision.
Consumers are encouraged to:
-
Purchase supplements from reputable UK retailers that carry third-party quality certification. Informed-Sport is the leading UK batch-testing programme and is recommended by UK Anti-Doping (UKAD); UKAD's supplement advice pages provide further guidance for athletes concerned about contamination risk.
-
Seek professional advice before starting any new supplement, particularly if you have an underlying health condition or are taking prescribed medication.
Overall, creatine remains a well-tolerated supplement for most healthy adults at recommended intakes, and concerns about hair loss — while worth monitoring — should be weighed against the broader context of limited and inconclusive evidence.
Frequently Asked Questions
Can creatine cause hair loss in women as well as men?
The theoretical risk applies to both sexes, as women can also develop androgenetic alopecia driven by DHT sensitivity, particularly those with PCOS or a family history of female pattern hair loss. However, no clinical studies have demonstrated that creatine causes hair loss in women, and the vast majority of female creatine users report no hair changes.
Is creatine safe to take long-term, and does the hair loss risk increase over time?
Creatine at recommended intakes is considered safe for healthy adults in the short to medium term, and long-term use at 3–5 g daily has not been shown to cause cumulative harm in most studies. Whether any DHT-raising effect — if real — worsens with prolonged use has not been studied, so those with a genetic predisposition to hair loss may wish to monitor their hair periodically.
What is the difference between creatine and anabolic steroids when it comes to hair loss?
Anabolic steroids directly raise androgen levels and are well-established causes of accelerated androgenetic alopecia, whereas creatine is not a steroid and does not directly stimulate testosterone production or bind to androgen receptors. Any influence creatine may have on DHT is indirect, modest, and unconfirmed — a fundamentally different risk profile to anabolic steroid use.
Can I take finasteride and creatine at the same time?
There is no known pharmacological interaction between finasteride and creatine, and finasteride — by blocking 5-alpha reductase — would theoretically counteract any DHT-raising effect creatine might have. However, finasteride is a prescription-only medicine in the UK and should only be taken under GP supervision; always discuss any supplements you are using with your prescribing clinician.
How do I know if my hair loss is caused by creatine or something else?
Creatine-related hair loss cannot be confirmed without ruling out more common causes such as iron or ferritin deficiency, thyroid dysfunction, telogen effluvium from stress, or a pre-existing genetic predisposition. A useful first step is pausing creatine for 8–12 weeks to see whether shedding stabilises, while your GP investigates other causes with appropriate blood tests.
Where can I report a suspected side effect from a creatine supplement in the UK?
Suspected adverse reactions to any supplement, including creatine, can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Reporting helps build the national evidence base for supplement safety and is encouraged for any unexpected health change you believe may be linked to a supplement.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
